MegaSyn is an AI model developed by Collaborations Pharmaceuticals (United States), first published in March 2022. It works in the medicine domain, on tasks such as drug discovery.
Epoch AI has no training-compute estimate for this model.
Access: Hosted access (no API). Its weights are not openly released. The reference paper has 148 citations.